Lung cancer remains the leading cause of cancer-relatedmortality, and KRAS mutations are foundin approximately 32% of cases, renderingthis mouse strain a highly relevant model system to test the effectivenessof Deltafluorine in cancer. The gene discussed is KRAS; the disease is lung carcinoma.